These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 21784687

  • 1. Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B.
    Sayan M, Akhan SC.
    Int J Infect Dis; 2011 Oct; 15(10):e722-6. PubMed ID: 21784687
    [Abstract] [Full Text] [Related]

  • 2. [HBV vaccine escape mutations in a chronic hepatitis B patient treated with nucleos(t)ide analogues].
    Sayan M, Buğdacı MS.
    Mikrobiyol Bul; 2013 Jul; 47(3):544-9. PubMed ID: 23971933
    [Abstract] [Full Text] [Related]

  • 3. [HBV pol/S gene mutations in chronic hepatitis B patients receiving nucleoside/nucleotide analogues treatment].
    Kırdar S, Yaşa MH, Sayan M, Aydın N.
    Mikrobiyol Bul; 2019 Apr; 53(2):144-155. PubMed ID: 31130119
    [Abstract] [Full Text] [Related]

  • 4. Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B.
    Sayan M, Sentürk O, Akhan SÇ, Hülagü S, Cekmen MB.
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e136-41. PubMed ID: 20382061
    [Abstract] [Full Text] [Related]

  • 5. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F, Vincenti D, Vairo F, Solmone M, Mariano A, Piselli P, Puro V, Capobianchi MR, Antonucci G.
    J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
    [Abstract] [Full Text] [Related]

  • 6. [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].
    Ji FZ, Wang L, Yang BH, Zhao JJ, Liu F, Xue Y, Li T.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):280-4. PubMed ID: 22964149
    [Abstract] [Full Text] [Related]

  • 7. Amino acid similarities and divergences in the small surface proteins of genotype C hepatitis B viruses between nucleos(t)ide analogue-naïve and lamivudine-treated patients with chronic hepatitis B.
    Ding H, Liu B, Zhao C, Yang J, Yan C, Yan L, Zhuang H, Li T.
    Antiviral Res; 2014 Feb; 102():29-34. PubMed ID: 24316031
    [Abstract] [Full Text] [Related]

  • 8. Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
    Salpini R, Svicher V, Cento V, Gori C, Bertoli A, Scopelliti F, Micheli V, Cappiello T, Spanò A, Rizzardini G, De Sanctis GM, Sarrecchia C, Angelico M, Perno CF.
    Antiviral Res; 2011 Nov; 92(2):382-5. PubMed ID: 21920388
    [Abstract] [Full Text] [Related]

  • 9. Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India.
    Kazim SN, Sarin SK, Sharma BC, Khan LA, Hasnain SE.
    Intervirology; 2006 Nov; 49(3):152-60. PubMed ID: 16428891
    [Abstract] [Full Text] [Related]

  • 10. Characterization of hepatitis B virus genotypes/subgenotypes in 1,301 patients with chronic hepatitis B in North China.
    Li XD, Wang L, Liu Y, Xu ZH, Dai JZ, Li L, Yao ZT, Xin SJ, Zhao JM, Xu DP.
    Chin Med J (Engl); 2011 Dec; 124(24):4178-83. PubMed ID: 22340383
    [Abstract] [Full Text] [Related]

  • 11. [The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B].
    Tang JL, Zhou JK.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):342-4. PubMed ID: 22338219
    [Abstract] [Full Text] [Related]

  • 12. [Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].
    Sayan M, Hülagü S, Akhan SC, Sentürk O, Meriç M, Cekmen M.
    Mikrobiyol Bul; 2009 Jul; 43(3):425-32. PubMed ID: 19795617
    [Abstract] [Full Text] [Related]

  • 13. Naturally occurring amino-acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B.
    Sayan M, Akhan SC, Meric M.
    J Viral Hepat; 2010 Jan; 17(1):23-7. PubMed ID: 19566788
    [Abstract] [Full Text] [Related]

  • 14. [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].
    Kalayci R, Altindiş M, Gülamber G, Demirtürk N, Akcan Y, Demirdal T.
    Mikrobiyol Bul; 2010 Apr; 44(2):237-43. PubMed ID: 20549958
    [Abstract] [Full Text] [Related]

  • 15. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
    Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo FF.
    J Gastroenterol Hepatol; 2010 Jan; 25(1):101-6. PubMed ID: 19817965
    [Abstract] [Full Text] [Related]

  • 16. Molecular genesis of drug-resistant and vaccine-escape HBV mutants.
    Locarnini SA, Yuen L.
    Antivir Ther; 2010 Jan; 15(3 Pt B):451-61. PubMed ID: 20516565
    [Abstract] [Full Text] [Related]

  • 17. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL, Netherlands Association of Gastroenterologists and Hepatologists.
    Neth J Med; 2008 Jan; 66(7):292-306. PubMed ID: 18663260
    [Abstract] [Full Text] [Related]

  • 18. Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.
    Sloan RD, Ijaz S, Moore PL, Harrison TJ, Teo CG, Tedder RS.
    Antivir Ther; 2008 Jan; 13(3):439-47. PubMed ID: 18572757
    [Abstract] [Full Text] [Related]

  • 19. Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy.
    Lok AS, Hussain M, Cursano C, Margotti M, Gramenzi A, Grazi GL, Jovine E, Benardi M, Andreone P.
    Hepatology; 2000 Nov; 32(5):1145-53. PubMed ID: 11050068
    [Abstract] [Full Text] [Related]

  • 20. Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.
    Li XG, Liu BM, Xu J, Liu XE, Ding H, Li T.
    J Med Virol; 2012 Feb; 84(2):207-16. PubMed ID: 22170539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.